Europe Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery

  • 52 views
Uploaded on

 

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
52
On Slideshare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
0
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. Europe Diabetes Care Devices Market Outlook to 2018 -Glucose Monitoring and Insulin DeliveryReport Details:Published:September 2012No. of Pages: 104Price: Single User License – US$3500Europe Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin DeliverySummaryGlobalData’s new report, “Europe Diabetes Care Devices Market Outlook to 2018 - GlucoseMonitoring and Insulin Delivery” provides key market data on the Europe Diabetes Care Devicesmarket – Germany, France, Italy, Spain and United Kingdom.. The report provides value (USDmillion) data for all the market categories – Glucose Monitoring and Insulin Delivery. The reportalso provides company shares and distribution shares data for each of the aforementioned marketcategories. The report is supplemented with global corporate-level profiles of the key marketparticipants.This report is built using data and information sourced from proprietary databases, primary andsecondary research and in-house analysis by GlobalData’s team of industry experts.Scope- Countries covered include Germany, France, Italy, Spain and United Kingdom..- Market size and company share data for Diabetes Care Devices market categories – InsulinDelivery and Glucose Monitoring.- Annualized market revenues (USD million) data for each of the market categories in each of thecountry. Data from 2004 to 2011, forecast forward for 7 years to 2018.- 2011 company shares and distribution shares data for each of the market categories andcountries.- Global corporate-level profiles of key companies operating within the Europe Diabetes CareDevices market.- Key players covered include F. Hoffmann-La Roche Ltd., Sanofi, Novo Nordisk A/S, Eli Lilly andCompany, LifeScan, Inc., Medtronic, Inc., Bayer HealthCare AG, Becton, Dickinson and Company,Abbott Laboratories, Animas Corporation and Ypsomed Holding AG.
  • 2. Reasons to buy- Develop business strategies by identifying the key market categories and segments poised forstrong growth.- Develop market-entry and market expansion strategies.- Design competition strategies by identifying who-stands-where in the Europe Diabetes CareDevices competitive landscape.- Develop capital investment strategies by identifying the key market segments expected toregister strong growth in the near future.- What are the key distribution channels and what’s the most preferred mode of productdistribution – Identify, understand and capitalize.Get your copy of this report @http://www.reportsnreports.com/reports/197473-europe-diabetes-care-devices-market-outlook-to-2018-glucose-monitoring-and-insulin-delivery.htmlMajor points covered in Table of Contents of this report include1 Table of Contents1 Table of Contents 21.1 List of Tables 61.2 List of Figures 82 Introduction 92.1 What is This Report About? 93 Diabetes Care Devices in Europe 103.1 Diabetes Care Devices Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018103.2 Diabetes Care Devices, Europe, Overall Revenue ($m), USD Constant, 2004-2018 113.3 Diabetes Care Devices, Europe, Company share (2010-2011) 164 Diabetes Care Devices In Germany 184.1 Diabetes Care Devices, Germany, Overall Revenue ($m), USD Constant, 2004-2018 184.2 Diabetes Care Devices, Germany, Distribution Share (2010-2011) 234.2.1 Glucose Monitoring, Germany, Distribution Share (2010-2011) 234.2.2 Insulin Delivery, Germany, Distribution Share (2010-2011) 234.3 Diabetes Care Devices, Germany, Company Share (2010-2011) 244.3.1 Diabetes Care Devices, Germany, Company Share (2010-2011) 244.3.2 Glucose Monitoring, Germany, Company Share (2010-2011) 264.3.3 Insulin Delivery, Germany, Company Share (2010-2011) 285 Diabetes Care Devices In France 305.1 Diabetes Care Devices, France, Overall Revenue ($m), USD Constant, 2004-2018 305.2 Diabetes Care Devices, France, Distribution Share (2010-2011) 355.2.1 Glucose Monitoring, France, Distribution Share (2010-2011) 355.2.2 Insulin Delivery, France, Distribution Share (2010-2011) 35
  • 3. 5.3 Diabetes Care Devices, France, Company Share (2010-2011) 365.3.1 Diabetes Care Devices, France, Company Share (2010-2011) 365.3.2 Glucose Monitoring, France, Company Share (2010-2011) 385.3.3 Insulin Delivery, France, Company Share (2010-2011) 406 Diabetes Care Devices In United Kingdom 426.1 Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant, 2004-2018 426.2 Diabetes Care Devices, United Kingdom, Distribution Share (2010-2011) 476.2.1 Glucose Monitoring, United Kingdom, Distribution Share (2010-2011) 476.2.2 Insulin Delivery, United Kingdom, Distribution Share (2010-2011) 476.3 Diabetes Care Devices, United Kingdom, Company Share (2010-2011) 486.3.1 Diabetes Care Devices, United Kingdom, Company Share (2010-2011) 486.3.2 Glucose Monitoring, United Kingdom, Company Share (2010-2011) 506.3.3 Insulin Delivery, United Kingdom, Company Share (2010-2011) 527 Diabetes Care Devices In Italy 547.1 Diabetes Care Devices, Italy, Overall Revenue ($m), USD Constant, 2004-2018 547.2 Diabetes Care Devices, Italy, Distribution Share (2010-2011) 597.2.1 Glucose Monitoring, Italy, Distribution Share (2010-2011) 597.2.2 Insulin Delivery, Italy, Distribution Share (2010-2011) 597.3 Diabetes Care Devices, Italy, Company Share (2010-2011) 607.3.1 Diabetes Care Devices, Italy, Company Share (2010-2011) 607.3.2 Glucose Monitoring, Italy, Company Share (2010-2011) 627.3.3 Insulin Delivery, Italy, Company Share (2010-2011) 648 Diabetes Care Devices In Spain 668.1 Diabetes Care Devices, Spain, Overall Revenue ($m), USD Constant, 2004-2018 668.2 Diabetes Care Devices, Spain, Distribution Share (2010-2011) 718.2.1 Glucose Monitoring, Spain, Distribution Share (2010-2011) 718.2.2 Insulin Delivery, Spain, Distribution Share (2010-2011) 718.3 Diabetes Care Devices, Spain, Company Share (2010-2011) 728.3.1 Diabetes Care Devices, Spain, Company Share (2010-2011) 728.3.2 Glucose Monitoring, Spain, Company Share (2010-2011) 748.3.3 Insulin Delivery, Spain, Company Share (2010-2011) 769 Overview of Key Companies in Europe Diabetes Care Devices Market 789.1 F. Hoffmann-La Roche Ltd. 789.1.1 Company Overview 789.1.2 Share in the Europe Diabetes Care Devices Market 789.2 Sanofi 799.2.1 Company Overview 799.2.2 Share in the Europe Diabetes Care Devices Market 799.3 Novo Nordisk A/S 809.3.1 Company Overview 809.3.2 Share in the Europe Diabetes Care Devices Market 809.4 Eli Lilly and Company 81
  • 4. 9.4.1 Company Overview 819.4.2 Share in the Europe Diabetes Care Devices Market 819.5 LifeScan, Inc. 829.5.1 Company Overview 829.5.2 Share in the Europe Diabetes Care Devices Market 829.6 Medtronic, Inc. 839.6.1 Company Overview 839.6.2 Share in the Europe Diabetes Care Devices Market 839.7 Bayer HealthCare AG 849.7.1 Company Overview 849.8 Becton, Dickinson and Company 849.8.1 Company Overview 849.9 Abbott Laboratories 859.9.1 Company Overview 859.10 Animas Corporation 859.10.1 Company Overview 859.11 Ypsomed Holding AG 869.11.1 Company Overview 869.12 Arkray, Inc. 869.12.1 Company Overview 869.13 Nipro Corporation 879.13.1 Company Overview 879.14 B. Braun Melsungen AG 879.14.1 Company Overview 879.15 Terumo Corporation 889.15.1 Company Overview 8810 Diabetes Care Devices Market Pipeline Products 8911 Financial Deals Landscape 9211.1 Partnerships 9211.1.1 Insulet Expands Distribution Agreement With Ypsomed Holding 9211.1.2 Insulet Amends Licensing Agreement With Abbott Diabetes 9311.1.3 Mendor Enters Into Distribution Agreement With Merck Serono 9412 Recent Developments 9512.1 Strategy And Business Planning 9512.1.1 Sep 05, 2012: Roche Provides Update On Its Strategy At Investor Conference 9512.1.2 Jun 26, 2012: Roche To Shut New Jersey Site, Eliminate 1,000 Jobs 9612.1.3 Nov 02, 2011: Sanofi To Shut Down R&D Site In Bridgewater, New Jersey 9712.1.4 Oct 13, 2011: Unisense Establishes US Headquarter 9712.2 Government and Public Interest 9812.2.1 May 23, 2012: Beta Cell Imaging Could Help Spot Diabetes Earlier: Vanderbilt University9813 Appendix 100
  • 5. 13.1 Definitions of Markets Covered in the Report 10113.1.1 Diabetes Care Devices 10113.2 Research Methodology 10213.3 Secondary Research 10213.4 Primary Research 10213.5 Models 10313.6 Forecasts 10313.7 Expert Panels 10313.8 GlobalData Consulting 10413.9 Currency Conversion 10413.10 Contact Us 10413.11 Disclaimer 1041.1 List of TablesTable 1: Diabetes Care Devices, Cross Country Comparison, Revenue ($m),USD Constant, 2004-2018 10Table 2: Diabetes Care Devices, Europe, Overall Revenue ($m), USD Constant, 2004-2018 11Table 3: Diabetes Care Devices, Europe, Overall Revenue ($m), USD Constant, Historic, 2004-2011 13Table 4: Diabetes Care Devices, Europe, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 15Table 5: Diabetes Care Devices, Europe, Company share by Revenue ($m), USD Constant, 2010-2011 17Table 6: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Constant, 2004-2018 18Table 7: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Constant, Historic, 2004-2011 20Table 8: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Constant, Forecast,2011-2018 22Table 9: Glucose Monitoring, Germany, Distribution Share by Revenue ($m), USD Constant,2010-2011 23Table 10: Insulin Delivery, Germany, Distribution Share by Revenue ($m), USD Constant, 2010-2011 23Table 11: Diabetes Care Devices, Germany, Company Share, USD Constant, (2010-2011) 25Table 12: Glucose Monitoring, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011 27Table 13: Insulin Delivery, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011 29Table 14: Diabetes Care Devices, France, Overall Revenue ($m), USD Constant, 2004-2018 30Table 15: Diabetes Care Devices, France, Overall Revenue ($m), USD Constant, Historic, 2004-2011 32Table 16: Diabetes Care Devices, France, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 34
  • 6. Table 17: Glucose Monitoring, France, Distribution Share by Revenue ($m), USD Constant, 2010-2011 35Table 18: Insulin Delivery, France, Distribution Share by Revenue ($m), USD Constant, 2010-2011 35Table 19: Diabetes Care Devices, France, Company Share, USD Constant, (2010-2011) 37Table 20: Glucose Monitoring, France, Company Share by Revenue ($m), USD Constant, 2010-2011 39Table 21: Insulin Delivery, France, Company Share by Revenue ($m), USD Constant, 2010-201141Table 22: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant, 2004-2018 42Table 23: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant,Historic, 2004-2011 44Table 24: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant,Forecast, 2011-2018 46Table 25: Glucose Monitoring, United Kingdom, Distribution Share by Revenue ($m), USDConstant, 2010-2011 47Table 26: Insulin Delivery, United Kingdom, Distribution Share by Revenue ($m), USD Constant,2010-2011 47Table 27: Diabetes Care Devices, United Kingdom, Company Share, USD Constant, (2010-2011)49Table 28: Glucose Monitoring, United Kingdom, Company Share by Revenue ($m), USDConstant, 2010-2011 51Table 29: Insulin Delivery, United Kingdom, Company Share by Revenue ($m), USD Constant,2010-2011 53Table 30: Diabetes Care Devices, Italy, Overall Revenue ($m), USD Constant, 2004-2018 54Table 31: Diabetes Care Devices, Italy, Overall Revenue ($m), USD Constant, Historic, 2004-201156Table 32: Diabetes Care Devices, Italy, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 58Table 33: Glucose Monitoring, Italy, Distribution Share by Revenue ($m), USD Constant, 2010-2011 59Table 34: Insulin Delivery, Italy, Distribution Share by Revenue ($m), USD Constant, 2010-201159Table 35: Diabetes Care Devices, Italy, Company Share, USD Constant, (2010-2011) 61Table 36: Glucose Monitoring, Italy, Company Share by Revenue ($m), USD Constant, 2010-201163Table 37: Insulin Delivery, Italy, Company Share by Revenue ($m), USD Constant, 2010-2011 65Table 38: Diabetes Care Devices, Spain, Overall Revenue ($m), USD Constant, 2004-2018 66Table 39: Diabetes Care Devices, Spain, Overall Revenue ($m), USD Constant, Historic, 2004-2011 68Table 40: Diabetes Care Devices, Spain, Overall Revenue ($m), USD Constant, Forecast, 2011-
  • 7. 2018 70Table 41: Glucose Monitoring, Spain, Distribution Share by Revenue ($m), USD Constant, 2010-2011 71Table 42: Insulin Delivery, Spain, Distribution Share by Revenue ($m), USD Constant, 2010-201171Table 43: Diabetes Care Devices, Spain, Company Share, USD Constant, (2010-2011) 73Table 44: Glucose Monitoring, Spain, Company Share by Revenue ($m), USD Constant, 2010-2011 75Table 45: Insulin Delivery, Spain, Company Share by Revenue ($m), USD Constant, 2010-201177Table 46: Diabetes Care DevicesMarket Pipeline Products 89Table 47: Insulet Expands Distribution Agreement With Ypsomed Holding 92Table 48: Insulet Amends Licensing Agreement With Abbott Diabetes 93Table 49: Mendor Enters Into Distribution Agreement With Merck Serono 941.2 List of FiguresFigure 1: Diabetes Care Devices, Cross Country Comparison, Revenue ($m), USD Constant,2004-2018 10Figure 2: Diabetes Care Devices, Europe, Overall Revenue ($m), USD Constant, 2004-2018 11Figure 3: Diabetes Care Devices, Europe, Overall Revenue ($m), USD Constant, Historic, 2004-2011 12Figure 4: Diabetes Care Devices, Europe, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 14Figure 5: Diabetes Care Devices, Europe, Company share (%), 2011 16Figure 6: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Constant, 2004-2018 18Figure 7: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Constant, Historic, 2004-2011 19Figure 8: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Constant, Forecast,2011-2018 21Figure 9: Diabetes Care Devices, Germany, Company Share (%), 2011 24Figure 10: Glucose Monitoring, Germany, Company Share (%), 2011 26Figure 11: Insulin Delivery, Germany, Company Share (%), 2011 28Figure 12: Diabetes Care Devices, France, Overall Revenue ($m), USD Constant, 2004-2018 30Figure 13: Diabetes Care Devices, France, Overall Revenue ($m), USD Constant, Historic, 2004-2011 31Figure 14: Diabetes Care Devices, France, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 33Figure 15: Diabetes Care Devices, France, Company Share (%), 2011 36Figure 16: Glucose Monitoring, France, Company Share (%), 2011 38Figure 17: Insulin Delivery, France, Company Share (%), 2011 40Figure 18: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant, 2004-2018 42
  • 8. Figure 19: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant,Historic, 2004-2011 43Figure 20: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant,Forecast, 2011-2018 45Figure 21: Diabetes Care Devices, United Kingdom, Company Share (%), 2011 48Figure 22: Glucose Monitoring, United Kingdom, Company Share (%), 2011 50Figure 23: Insulin Delivery, United Kingdom, Company Share (%), 2011 52Figure 24: Diabetes Care Devices, Italy, Overall Revenue ($m), USD Constant, 2004-2018 54Figure 25: Diabetes Care Devices, Italy, Overall Revenue ($m), USD Constant, Historic, 2004-2011 55Figure 26: Diabetes Care Devices, Italy, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 57Figure 27: Diabetes Care Devices, Italy, Company Share (%), 2011 60Figure 28: Glucose Monitoring, Italy, Company Share (%), 2011 62Figure 29: Insulin Delivery, Italy, Company Share (%), 2011 64Figure 30: Diabetes Care Devices, Spain, Overall Revenue ($m), USD Constant, 2004-2018 66Figure 31: Diabetes Care Devices, Spain, Overall Revenue ($m), USD Constant, Historic, 2004-2011 67Figure 32: Diabetes Care Devices, Spain, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 69Figure 33: Diabetes Care Devices, Spain, Company Share (%), 2011 72Figure 34: Glucose Monitoring, Spain, Company Share (%), 2011 74Figure 35: Insulin Delivery, Spain, Company Share (%), 2011 76Figure 36: F. Hoffmann-La Roche Ltd., Company Share (%), Europe Diabetes Care DevicesMarket, 2011 78Figure 37: Sanofi, Company Share (%), Europe Diabetes Care Devices Market, 2011 79Figure 38: Novo Nordisk A/S Company Share (%), Europe Diabetes Care Devices Market, 201180Figure 39: Eli Lilly and Company, Company Share (%), Europe Diabetes Care Devices Market,2011 81Figure 40: LifeScan, Inc., Company Share (%), Europe Diabetes Care Devices Market, 2011 82Figure 41: Medtronic, Inc., Company Share (%), Europe Diabetes Care Devices Market, 2011 83Contact: sales@reportsandreports.com for more information.